Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Q&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD

Published Date: 11 Nov 2026

Q&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD

The HCPFive: Top News for Healthcare Providers from the Week of 11/1

Published Date: 11 Nov 2026

The HCPFive: Top News for Healthcare Providers from the Week of 11/1

FDA Action Update, October 2026: Approval, Acceptance, and Designations Isabella Ciccone, MPH

Published Date: 11 Nov 2026

Catch up on any of the neurology headlines you may have missed in October 2026, compiled into 1 place by the NeurologyLive® team.

T-Cell Engager Cizutamig Shows Early Efficacy Signal in Generalized Myasthenia Gravis Marco Meglio

Published Date: 11 Nov 2026

Interim phase 1b data showed cizutamig produced rapid, sustained improvement in generalized myasthenia gravis with no cases of cytokine release syndrome.

SHASTA-3/4: Plozasiran Could Cut Acute Pancreatitis Risk by 78% Across sHTG Spectrum

Published Date: 11 Nov 2026

SHASTA-3/4: Plozasiran Could Cut Acute Pancreatitis Risk by 78% Across sHTG Spectrum

Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials

Published Date: 11 Nov 2026

Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials

Unmet Needs in HS and Emerging Oral Options, With Martina Porter, MD

Published Date: 11 Nov 2026

Unmet Needs in HS and Emerging Oral Options, With Martina Porter, MD

3-Year BE HEARD Data Link Bimekizumab to Fewer HS Draining Tunnels

Published Date: 11 Nov 2026

3-Year BE HEARD Data Link Bimekizumab to Fewer HS Draining Tunnels

Knowledge Hub

Oncology

Teaching Treatment Toxicity Recognition in Oncology: A Clinical and Evidence-Based Review

An evidence-based review of oncology treatment toxicity recognition, diagnosis, management, guideline recommendations, and educational strategies for healthcare professionals.

Oncology

Digital Cancer Survivorship Record Platforms: Clinical Utility, Governance, and Future Directions

A clinical review of digital cancer survivorship record platforms, including their uses, risks, governance, guideline alignment, and future potential.

Oncology

Forecasting Durable Cancer Control Through Tumor Clonal Succession Patterns After Local Therapy

A clinical review of how tumor clonal succession after local therapy may forecast recurrence risk and guide personalized cancer surveillance and treatment.

Oncology

Emerging Trends in Oncology and Precision Medicine

A clinical review of emerging oncology trends, precision biomarkers, novel therapies, guideline-based care, and the future of precision medicine.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Q&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD

The HCPFive: Top News for Healthcare Providers from the Week of 11/1

FDA Action Update, October 2026: Approval, Acceptance, and Designations Isabella Ciccone, MPH

T-Cell Engager Cizutamig Shows Early Efficacy Signal in Generalized Myasthenia Gravis Marco Meglio

SHASTA-3/4: Plozasiran Could Cut Acute Pancreatitis Risk by 78% Across sHTG Spectrum

Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials

Unmet Needs in HS and Emerging Oral Options, With Martina Porter, MD

3-Year BE HEARD Data Link Bimekizumab to Fewer HS Draining Tunnels

Knowledge Hub

Teaching Treatment Toxicity Recognition in Oncology: A Clinical and Evidence-Based Review

Digital Cancer Survivorship Record Platforms: Clinical Utility, Governance, and Future Directions

Forecasting Durable Cancer Control Through Tumor Clonal Succession Patterns After Local Therapy

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Q&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD

The HCPFive: Top News for Healthcare Providers from the Week of 11/1

FDA Action Update, October 2026: Approval, Acceptance, and Designations Isabella Ciccone, MPH

T-Cell Engager Cizutamig Shows Early Efficacy Signal in Generalized Myasthenia Gravis Marco Meglio

SHASTA-3/4: Plozasiran Could Cut Acute Pancreatitis Risk by 78% Across sHTG Spectrum

Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials

Unmet Needs in HS and Emerging Oral Options, With Martina Porter, MD

3-Year BE HEARD Data Link Bimekizumab to Fewer HS Draining Tunnels

Knowledge Hub

Teaching Treatment Toxicity Recognition in Oncology: A Clinical and Evidence-Based Review

Digital Cancer Survivorship Record Platforms: Clinical Utility, Governance, and Future Directions

Forecasting Durable Cancer Control Through Tumor Clonal Succession Patterns After Local Therapy

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views